Table 1. Characteristics of the leukemia patients.
| Parameter | Number | ||||||
|---|---|---|---|---|---|---|---|
| Patient designation | AML M4 (I) | AML M4 (II) | AML M4/M5 | AML M5 | CMML (I) | CMML (II) | CMML (III) |
| Age | 51 | 78 | 81 | 74 | 91 | 79 | n.i. |
| Gender | Female | Male | Male | Male | Female | Male | n.i. |
| FAB subtype | AML M4 (AMML) | AML M4 (AMML) | AML M4/M5 | AML M5 | CMML-2 | CMML-2 | CMML-2 |
| WBC (G/L) | 80.7 | 88.7 | 113.4 | 104.9 | 105.7 | 4.9 | n.i. |
| % Monocytes | 3 | 1 | 44 | 6 | 9 | 23.6 | n.i. |
| Hemoglobin (g/L) | 91 | 116 | 10 | 83 | 98 | 119 | n.i. |
| Platelet count (G/L) | 28 | 45 | 134 | 128 | 64 | 258 | n.i. |
| Previous treatment | No | No | No | No | No | No | No |
| CD64+ CD33+ (%) | 70 | 73 | 71 | 20 | 69 | 74 | 53 |
| CD64+ cells (%) | 70 | 73 | 73 | 23 | 70 | 74 | 53 |
FAB = French-American-British classification; n. i. = no information.